Growth Hormone Releasing Peptide-2 (GHRP-2) is a synthetic hexapeptide widely utilized in preclinical research to investigate growth hormone secretagogue receptor (GHS-R1a) activation and anterior pituitary signaling. When seeking to buy original GHRP-2 for laboratory assays, structural verification, precise sequence synthesis, and rigorous analytical testing are critical to ensure reproducible scientific data.
Growth Hormone Releasing Peptide-2 (GHRP-2) is a synthetic hexapeptide widely utilized in preclinical research to investigate growth hormone secretagogue receptor (GHS-R1a) activation and anterior pituitary signaling. When seeking to buy original GHRP-2 for laboratory assays, structural verification, precise sequence synthesis, and rigorous analytical testing are critical to ensure reproducible scientific data.
To buy original GHRP-2 for laboratory research, investigators must ensure the compound is verified via reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS) with guaranteed purity exceeding 98%. Authentic GHRP-2 (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2) requires lot-specific documentation confirming chemical identity, correct molecular mass (818.0 g/mol), and low endotoxin thresholds prior to in vitro or in vivo experimentation.
Obtaining genuine research peptides requires partnering with suppliers that maintain transparent analytical protocols. Substandard or mislabeled secretagogues compromise research integrity, altering receptor binding kinetics and yielding non-reproducible data in pituitary signaling assays. PX1 Research provides fully documented, USA-manufactured GHRP-2 accompanied by public, lot-specific Certificates of Analysis (COAs) independently verified by ISO 17025 accredited testing facilities.
GHRP-2, structurally known as pralmorelin, is a synthetic hexapeptide with the chemical sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2. It belongs to the class of unnatural amino acid-containing peptides designed to resist enzymatic degradation by circulating endopeptidases. The inclusion of D-naphthylalanine and D-phenylalanine residues imparts conformational stability, extending its terminal half-life in extracellular fluid environments compared to endogenous peptide ligands.
The molecular formula of GHRP-2 is C45H55N9O6, corresponding to a monoisotopic mass of 817.43 Da and a nominal molecular weight of 818.0 g/mol. In solid state, original GHRP-2 presents as a lyophilized white powder that must be stored under controlled thermal conditions to prevent hydrolysis or oxidation of the tryptophan residue. Detailed structural analysis via nuclear magnetic resonance (NMR) spectroscopy and electrospray ionization mass spectrometry (ESI-MS) confirms that authentic batches lack truncated sequence impurities or residual protective group adducts from solid-phase peptide synthesis (SPPS).
Preclinical studies indicate that GHRP-2 acts as a potent agonist at the growth hormone secretagogue receptor type 1a (GHS-R1a), a 7-transmembrane G-protein coupled receptor (GPCR) predominantly expressed in the anterior pituitary gland and hypothalamus. Binding of GHRP-2 to GHS-R1a triggers a conformational change that activates the Gq/11 protein subunit pathway, downstream stimulating phospholipase C (PLC).
The activation of PLC results in the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 subsequently binds to ligand-gated calcium channels on the endoplasmic reticulum, prompting a rapid mobilization of intracellular calcium ([Ca2+]i). This localized calcium influx facilitates the exocytosis of pre-stored growth hormone granules from pituitary somatotrophs. In vitro data demonstrate that this pathway operates independently of growth hormone-releasing hormone (GHRH) receptor activation, though synergistic signaling is observed when both pathways are stimulated concurrently.
In animal models, including rodent and non-human primate research systems, GHRP-2 administration has demonstrated robust stimulation of pulsatile growth hormone secretion. Pharmacokinetic profiling in rodent models reveals rapid absorption kinetics following parenteral administration, with peak plasma concentrations typically recorded within 15 to 30 minutes post-exposure. Research published in endocrinology literature highlights that GHRP-2 displays greater potency in stimulating somatotroph release than early-generation secretagogues.
Additionally, preclinical trials evaluating central and peripheral ghrelin receptor pathway dynamics note that GHRP-2 possesses weak orexigenic activity mediated through hypothalamic arcuate nucleus stimulation. In vitro hypothalamic slice preparations indicate that GHRP-2 activates neuropeptide Y (NPY) and agouti-related peptide (AgRP) neurons to a lesser extent than native ghrelin, rendering it a valuable tool for isolating somatotrophic pathway activation from metabolic feeding behavior signals in comparative growth hormone secretagogues research.
When designing receptor binding or pituitary secretion studies, researchers often compare GHRP-2 against other prominent secretagogues within the growth hormone secretagogue family. While all three compounds target GHS-R1a, their selectivity, potency, and secondary signaling profiles exhibit notable differences in preclinical models.
Comparative assays demonstrate that GHRP-6 exhibits higher orexigenic signaling via hypothalamic NPY pathways, whereas GHRP-2 displays greater binding affinity and somatotroph release potency. Conversely, Ipamorelin represents a highly selective pentapeptide secretagogue that stimulates GH release without triggering significant secondary cortisol or prolactin release in animal models. In contrast, researchers utilizing CJC-1295 No DAC study GHRH receptor stimulation rather than GHS-R1a agonism, making co-administration models frequent targets for investigating pathway synergy. Exploring the broader range of compounds in our all peptides library allows research teams to select the exact molecular tools needed for specific receptor binding assays.
Ensuring that a research batch represents authentic, unadulterated GHRP-2 requires comprehensive analytical verification. Reliable sourcing depends on rigorous quality control measures performed on every single synthesis lot. Key testing parameters include:
1. High-Performance Liquid Chromatography (RP-HPLC): RP-HPLC chromatograms establish chemical purity by separating the target peptide from synthesis side-products, deletion sequences, or degradation fragments. High-grade research compounds must yield a major peak area corresponding to ≥98.0% purity at 214 nm or 220 nm UV detection.
2. Mass Spectrometry (MS): Electrospray ionization mass spectrometry (ESI-MS) confirms the exact molecular weight of the peptide. A clean spectrum displaying the primary [M+H]+ or [M+2H]2+ ions confirms correct amino acid assembly without truncation or amino acid substitution errors.
3. Endotoxin Testing (LAL Assay): For cell culture and in vivo animal models, bacterial endotoxins (lipopolysaccharides) introduce biological noise and inflammatory responses. Analytical testing via Chromogenic Limulus Amebocyte Lysate (LAL) assay ensures endotoxin levels remain strictly below standard research limits (<0.1 EU/mg).
4. Moisture and Residual Solvent Analysis: Karl Fischer titration and gas chromatography ensure low residual moisture and volatile organic solvent levels, maintaining chemical stability during storage.
Lyophilized GHRP-2 exhibits optimal stability when stored in a dedicated laboratory freezer at -20°C or -80°C, isolated from light and moisture. Sealed vials kept under desiccation at these temperatures remain stable for extended periods without significant peptide bond hydrolysis or oxidation.
For laboratory assay preparation, lyophilized peptides must be reconstituted using sterile laboratory-grade solvents such as bacteriostatic water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl), depending on downstream experimental compatibility. Reconstitution protocols should involve allowing the vial to reach room temperature before adding the solvent along the internal glass wall. Gentle swirling or manual rotation is recommended; vigorous vortexing or mechanical agitation must be avoided as shear forces can induce peptide aggregation or denaturation. Reconstituted solutions should be aliquoted into single-use polypropylene tubes and stored at 2°C to 8°C for short-term assays, or frozen at -80°C to minimize freeze-thaw degradation cycles.
In primary pituitary cell culture models, researchers utilize GHRP-2 to map the intracellular cascades governing hormone synthesis and exocytosis. By applying selective protein kinase C (PKC) inhibitors or intracellular calcium chelators (such as BAPTA-AM), investigators can isolate the specific contributions of IP3-mediated calcium release versus voltage-gated calcium entry through L-type channels during secretagogue stimulation.
In rodent metabolic research, GHRP-2 serves as a reference ligand in studies investigating systemic somatotrophic axis activation, nitrogen retention, and muscle protein synthesis pathways (e.g., Akt/mTOR phosphorylation). Reviewing detailed technical documentation in our research library provides laboratory personnel with comparative literature on secretagogue receptor affinity, binding constants (Kd), and cell culture dosing protocols for in vitro experimentation.
The presence of low-quality or counterfeit peptides in the research pipeline presents a major challenge to scientific reproducibility. Research teams must recognize common supplier deficiencies that signal unreliable product quality:
Lack of Lot-Specific COAs: Authentic suppliers provide accessible, lot-matched analytical reports rather than generic or recycled template certificates.
Absence of Mass Spec Data: Relying solely on HPLC without MS confirmation leaves open the possibility of incorrect sequence assembly or identical-retention-time impurities.
Undisclosed Manufacturing Origin: High-precision research compounds require stringent quality management. Suppliers operating outside accredited, GMP-compliant facilities risk batch-to-batch variability and heavy metal contamination.
Inadequate Storage and Packaging: Peptides shipped in unsealed, non-evacuated containers or subjected to excessive heat during transit undergo rapid degradation, yielding inactive peptide fragments in research assays.
PX1 Research is committed to supplying institutions, university laboratories, and independent researchers with reference-grade research peptides. Every batch of our original GHRP-2 is manufactured in the USA under strict quality control standards, ensuring sequence fidelity and structural integrity.
We validate every synthesis lot through independent ISO 17025 accredited testing laboratories. Facilities procuring materials for large-scale screening protocols or multi-center research projects can access bulk volume discounts and institutional supply contracts through our wholesale accounts program. All orders ship directly from our climate-controlled distribution centers in California and Arizona, with same-day fulfillment for orders placed Monday through Friday.
What is GHRP-2 and how is it defined in research settings?
GHRP-2 (Growth Hormone Releasing Peptide-2, or pralmorelin) is a synthetic hexapeptide that acts as an agonist at the growth hormone secretagogue receptor (GHS-R1a). In research settings, it is used to study pituitary signaling, calcium mobilization, and growth hormone release kinetics.
How can I verify that I am buying original GHRP-2?
Original GHRP-2 is verified by reviewing lot-specific Certificates of Analysis featuring RP-HPLC (confirming ≥98% purity) and Mass Spectrometry (confirming correct molecular mass of 818.0 Da). Ensure the supplier provides independent third-party testing from an ISO 17025 accredited laboratory.
What is the difference between GHRP-2 and GHRP-6?
While both are GHS-R1a agonists, GHRP-2 exhibits higher potency for growth hormone release in preclinical models and lower orexigenic (appetite-stimulating) activity compared to GHRP-6.
What solvents are suitable for reconstituting GHRP-2 for in vitro research?
GHRP-2 is typically reconstituted using sterile laboratory-grade bacteriostatic water or sterile normal saline (0.9% NaCl), depending on the specific requirements of the cell culture or analytical assay.
How should lyophilized GHRP-2 be stored upon arrival at the laboratory?
Lyophilized GHRP-2 should be stored in a freezer at -20°C or -80°C, protected from light and moisture. Under these conditions, the peptide maintains chemical stability for extended periods.
Does PX1 Research provide third-party testing for GHRP-2?
Yes. Every lot of GHRP-2 from PX1 Research undergoes third-party verification at an ISO 17025 accredited laboratory, including RP-HPLC purity analysis, mass spectrometry sequence verification, and endotoxin testing.
What is the molecular weight and sequence of GHRP-2?
GHRP-2 has a molecular weight of 818.0 g/mol and the chemical sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2.
Is GHRP-2 approved for human consumption or clinical use?
No. GHRP-2 supplied by PX1 Research is strictly designated for laboratory research, in vitro assays, and preclinical animal models. It is not for human or veterinary consumption.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.